The classification of drugs varies from country to country, with active foods, dietary supplements and traditional medicines being included in certain categories. The stability of those products is also unknown and complex to the critical problem in the analysis of herbal products that this is a complex ingredient combination, as well as the elements responsible for the treatment effects. In order to identify the changes to the newly introduced regulations or regulations, detailed literary searches and online searches for herbal medicinal products regulations have been made in South-east Asia and European countries. Curcumin is an important pharmaceutical compound derived from turmeric. Curcumin is extracted from dried curcuma longa rhizomes. The demand for curcumin grows daily due to its use in the treatment of a number of diseases. Curcumin has long established challenges with its health benefits, such as poor uptake and poor bioavailability.

The classic method for extracting anthocyanins from plant tissues is the same as for other phenolics: the tissues are soaked and then extracted with a solvent in a process known as Solid Liquid Extraction. Modern approaches to anthocyanins extraction include;Supercritical fluid extraction, Ultrasound-assisted extraction, Pressurized liquid extraction, Microwave-assisted extraction, Ohmic heating-assisted extraction, Precipitation, and Solid phase extraction. The aim of this article is to review the methods used for Anthocyanins extraction from Hibiscus Sabdariffa.The study for the same has been done at Charak’s Pharmacognosy Laboratory, MIT-WPU School of Pharmacy, Pune. Usually, modern methods seem to have an edge againsttraditional methods in extraction procedures. This article discusses these methodsand tries to identify if it is the case in the case of anthocyanins extraction from Hibiscus sabdariffa L.while individually commenting on the method’s advantages or disadvantages too.

Aims: Healthcare and pharmaceutical research are incessantly reaching to new zeniths which is substantiated by the increasing numbers of diagnostic and therapeutic options available to healthcare professionals for treating patients but a major impediment to this growth has been the evolution of genetic mutation that makes diagnosis and treatment an enigmatic job. Unfortunately, the study of etiology of mutations is still a very neonatal area of research due to the high number of different factors involved in cellular signal trafficking, several metabolic pathways and their simultaneous effects. Owing to these reasons it has been very difficult to select an appropriate treatment modality based on the manifestations of certain common mutations in a pack of symptoms especially in patients who are resistant to treatment. This has led to the development of personalized therapy which can be delineated as acclimatizing of medical treatment based on the characteristics of the individual being treated. This development leans on our understanding of how an individual ingrained molecular and genetic profile makes them prone to certain diseases. To discover a right target for personalized therapies a long screening proses along with In vivo and in vitro analysis are needed. To begin with this review is an attempt to summarize the information available for personalized therapies.